Veracyte CEO shares withheld for tax on RSUs
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
VERACYTE, INC. Chief Executive Officer Marc Stapley reported a tax-related share disposition. On March 2, 2026, 19,455 shares of common stock were withheld to satisfy tax obligations tied to vesting restricted stock units at a reference price of $36.01 per share. Following this withholding, he directly owns 403,077 shares of Veracyte common stock. The footnote clarifies this was not an open-market sale but a tax-withholding transaction.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise Price or Tax Liability | Common Stock | 19,455 | $36.01 | $701K |
Footnotes (1)
- F1. Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on March 2, 2026 and does not represent a sale.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Veracyte (VCYT) report for CEO Marc Stapley?
Does the Veracyte Form 4 for Marc Stapley represent an open-market stock sale?
What transaction code is used in Marc Stapley’s Veracyte Form 4 and what does it mean?
AI-generated analysis. How Rhea-AI works. Not financial advice.